Commenting today on the Centers for Medicare & Medicaid Services’ proposed calendar year 2023 payment rule for hospital outpatients and ambulatory surgical centers, AHA said it supports the agency’s decision to end its unlawful cuts to 340B hospitals and urged the agency to promptly restore 340B hospital payments for CYs 2018-2022 without penalizing other hospitals. AHA also voiced support for the agency’s proposal to use Medicare claims data to calculate the monthly facility rate for Rural Emergency Hospitals, and urged the agency to detail the payment methodology and monitor its adequacy going forward. 
 
However, AHA strongly urged the agency to increase the rule’s proposed market basket update and reduce its productivity adjustment to reflect the unprecedented inflationary environment hospitals and health systems are experiencing. It also urged CMS not to add facet joint interventions to its prior authorization process, as other oversight mechanisms are available that do not delay appropriate care. 
 
Among other issues, AHA commented on CMS’s proposal to exempt rural Sole Community Hospitals from the site-neutral clinic visit payment cuts; organ acquisition payments; and a request for information regarding the use of CMS data to drive competition in health care marketplaces.

Related News Articles

Headline
Deceptively branded as an effort to save the 340B program, a legislative campaign by the Pharmaceutical Research and Manufacturers of America, National…
Headline
The Centers for Medicare & Medicaid Services today instructed certified independent dispute resolution entities to resume making payment determinations for…
Headline
The Centers for Medicare & Medicaid Services yesterday proposed requiring skilled nursing facilities participating in the Medicare and Medicaid…
Headline
Following the recent district court decision to remand to the Department of Health and Human Services the question of how to repay 340B hospitals for…
Headline
Drugmakers that participate in the 340B drug pricing program do not have to provide discounted 340B drugs to an unlimited number of contract pharmacies, the U.…
Headline
As drug prices continue to rise, the 340B drug pricing program continues to help hospitals expand access to comprehensive health services, including lifesaving…